These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20087043)

  • 1. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases treated with trastuzumab as primary chemotherapy].
    Murakami K; Sakata H; Miyazawa Y; Matsushita K; Akutsu Y; Nishimori T; Yoneyama Y; Usui A; Kano M; Matsubara H; Ochiai T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1683-7. PubMed ID: 17940391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer.
    Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M
    Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
    Untch M; Fasching PA; Konecny GE; Hasmüller S; Lebeau A; Kreienberg R; Camara O; Müller V; du Bois A; Kühn T; Stickeler E; Harbeck N; Höss C; Kahlert S; Beck T; Fett W; Mehta KM; von Minckwitz G; Loibl S
    J Clin Oncol; 2011 Sep; 29(25):3351-7. PubMed ID: 21788566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.
    Mazouni C; Hall A; Broglio K; Fritsche H; Andre F; Esteva FJ; Hortobagyi GN; Buzdar AU; Pusztai L; Cristofanilli M
    Cancer; 2007 Feb; 109(3):496-501. PubMed ID: 17149760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response].
    Rai Y; Sagara Y; Sagara Y; Takahama T; Matsuyama Y; Ando M; Sagara Y; Ooi Y; Inoue K; Kurosumi M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):65-8. PubMed ID: 17220672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].
    Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].
    Rai Y; Takahama T; Sagara Y; Sagara Y; Matsuyama Y; Ando M; Sagara Y; Ooi Y
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1297-300. PubMed ID: 16969028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience.
    Horiguchi J; Oyama T; Takata D; Rokutanda N; Nagaoka R; Odawara H; Tokiniwa H; Tozuka K; Kikuchi M; Sato A; Takeyoshi I
    Anticancer Res; 2011 Sep; 31(9):3041-6. PubMed ID: 21868556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of locally advanced breast cancer successfully treated by pre-operative systemic therapy using paclitaxel and trastuzumab].
    Suda T; Ishiguro K; Nishimura M
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):979-81. PubMed ID: 18633228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of multicentric breast cancer in which an effect of neoadjuvant chemotherapy had a disparity].
    Kashiwagi S; Kawajiri H; Noda S; Takashima T; Onoda N; Nakata B; Kato Y; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2775-7. PubMed ID: 21224709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice.
    Pernas S; Gil-Gil M; de Olza MO; Gumà A; Climent F; Petit A; Pla MJ; García-Tejedor A; López-Ojeda A; Falo C; Fernandez-Otega A; Mesia C; Pérez-Martin FJ; Urruticoechea A; Germà JR
    Breast Cancer Res Treat; 2012 Aug; 134(3):1161-8. PubMed ID: 22772380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
    Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases].
    Tohnosu N; Kobayashi Y; Saito T; Shimizu T; Natsume T; Tanaka H; Maruyama T; Watanabe Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):989-92. PubMed ID: 12894716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.
    Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H
    Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent breast cancer obtained long-term survival with local treatment(surgery and stereotactic body radiotherapy)and systemic therapy].
    Morioka E; Ohno Y; Noguchi M; Nakano Y; Noguchi M; Kosaka T; Takanaka T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1942-4. PubMed ID: 23267937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A long-surviving case of HER2-positive breast cancer with brain metastasis treated by multidisciplinary therapy].
    Sugimoto H; Nakagawa T; Sato T; Nagahara M; Ishiba T; Kasahara M; Kawachi H; Kubota K; Sugihara K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2071-3. PubMed ID: 23267980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.